{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:05:47Z","timestamp":1762542347577,"version":"build-2065373602"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.clml.2014.06.020","type":"journal-article","created":{"date-parts":[[2014,12,5]],"date-time":"2014-12-05T17:54:17Z","timestamp":1417802057000},"page":"S96-S103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S","title":["HIV-Related Hematological Malignancies: A\u00a0Concise Review"],"prefix":"10.1016","volume":"14","author":[{"given":"Adan","family":"Rios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2014.06.020_bib1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM200106073442306","article-title":"AIDS\u2014the first 20 years","volume":"344","author":"Sepkowitz","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.06.020_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.279.6.450","article-title":"Improved survival among HIV-infected individuals following initiation of anti-retroviral therapy","volume":"279","author":"Hogg","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2014.06.020_bib3","unstructured":"Veneman A. Point of view: child survival in Africa \u2013 seven signs of hope. UNICEF Press Centre May 28, 2008. Available at: http:\/\/www.unicef.org\/media\/index_44202.html. Accessed July 19, 2014."},{"key":"10.1016\/j.clml.2014.06.020_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2014.06.020_bib5","first-page":"811","article-title":"AIDS-related non-Hodgkin lymphoma in the first decade of highly active antiretroviral therapy","volume":"99","author":"Palmieri","year":"2006","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.clml.2014.06.020_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","article-title":"Human viral oncogenesis: a cancer hallmark analysis","volume":"15","author":"Mesri","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clml.2014.06.020_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/QCO.0b013e3283213080","article-title":"Non-AIDS-defining cancers","volume":"22","author":"Stebbing","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.clml.2014.06.020_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","article-title":"Malignacies in HIV\u2216AIDS: from epidemiology to therapeutic challenges","volume":"28","author":"Rubinstein","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.clml.2014.06.020_bib9","series-title":"The M.D. Anderson Manual of Medical Oncology","first-page":"1141","article-title":"AIDS-related malignancies","author":"Rios","year":"2011"},{"key":"10.1016\/j.clml.2014.06.020_bib10","first-page":"250","article-title":"Pneumocystis pneumonia\u2013Los Angeles","volume":"30","author":"Centers for Disease Control (CDC)","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clml.2014.06.020_bib11","first-page":"305","article-title":"Kaposi's sarcoma and pneumocystis pneumonia among homosexual men\u2014New York City and California","volume":"30","author":"Centers for Disease Control (CDC)","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clml.2014.06.020_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/bmb\/58.1.7","article-title":"The global epidemiology of HIV\/AIDS","volume":"58","author":"Morison","year":"2001","journal-title":"Br Med Bull"},{"key":"10.1016\/j.clml.2014.06.020_bib13","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJM200106073442312","article-title":"AIDS\u2013past and future","volume":"344","author":"Gottlieb","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.06.020_bib14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJMcp051203","article-title":"Management of newly diagnosed HIV infection","volume":"353","author":"Hammer","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.06.020_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0090-1229(86)90070-X","article-title":"Infectious complications of the primary immunodeficiencies","volume":"40","author":"Stiehm","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.clml.2014.06.020_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/00007890-199905150-00007","article-title":"Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients1. Groupe Cooperatif de Transplantation d'Ile de France (GCIF)","volume":"67","author":"Farge","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.clml.2014.06.020_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphoytopic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barr\u00e9-Sinoussi","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.clml.2014.06.020_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.287.5453.607","article-title":"AIDS as a zoonosis: scientific and public health implications","volume":"287","author":"Hahn","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.clml.2014.06.020_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/17130","article-title":"Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes","volume":"397","author":"Gao","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.clml.2014.06.020_bib20","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1128\/jvi.70.6.3617-3627.1996","volume":"70","author":"Chen","year":"1996","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.clml.2014.06.020_bib21","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.1993.03510170073033","article-title":"Epidemiology and transmission of HIV-2: why there is no HIV-2 pandemic","volume":"270","author":"De Cock","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2014.06.020_bib22","article-title":"Do clades matter for HIV vaccines?","volume":"7","author":"Kahn","year":"2003","journal-title":"IAVI Rep"},{"key":"10.1016\/j.clml.2014.06.020_bib23","unstructured":"UNAIDS Word AIDS Day Report. Results 2012. Available at: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/JC2434_WorldAIDSday_results_en.pdf. Accessed July 19, 2014."},{"key":"10.1016\/j.clml.2014.06.020_bib24","first-page":"395","article-title":"Structure and regulation of the human AIDS virus","volume":"3","author":"Kieny","year":"1990","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clml.2014.06.020_bib25","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1128\/JVI.01799-08","article-title":"Reassessing the human immunodeficiency virus type 1 life cycle through age-structured modeling: life span of infected cells, viral generation time, and basic reproductive number, R0","volume":"15","author":"Althaus","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.clml.2014.06.020_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection","volume":"373","author":"Ho","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.clml.2014.06.020_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20041464","article-title":"Getting to the guts of HIV pathogenesis","volume":"200","author":"Veazey","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.clml.2014.06.020_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.280.5362.427","article-title":"Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection","volume":"280","author":"Veazey","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.clml.2014.06.020_bib29","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1161121","article-title":"Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection","volume":"321","author":"Santiago","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.clml.2014.06.020_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1054-3589(07)56016-3","article-title":"The viral etiology of AIDS-associated malignancies","volume":"56","author":"Angeletti","year":"2008","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.clml.2014.06.020_bib31","first-page":"371","article-title":"Risks of T-cell lymphomas in persons with AIDS","volume":"26","author":"Biggar","year":"2001","journal-title":"J\u00a0AIDS"},{"key":"10.1016\/j.clml.2014.06.020_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV infected population in the USA","volume":"103","author":"Shiels","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2014.06.020_bib33","series-title":"WHO Classification of Tumors of Haemotopoietic and Lymphoid Tissues","first-page":"340","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.clml.2014.06.020_bib34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3816\/CLM.2007.n.002","article-title":"Clinical and immunologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy","volume":"4","author":"Barclay","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.clml.2014.06.020_bib35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","article-title":"AIDS-related lymphomas: from pathogenesis to pathology","volume":"130","author":"Carbone","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.06.020_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/COH.0b013e328319bcd1","article-title":"What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients","volume":"1","author":"Vajdic","year":"2009","journal-title":"Curr Opin HIV\/AIDS"},{"key":"10.1016\/j.clml.2014.06.020_bib37","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.clml.2014.06.020_bib38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.06.020_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0065-230X(00)79006-3","article-title":"Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?","volume":"79","author":"Longnecker","year":"2000","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.clml.2014.06.020_bib40","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/QAD.0b013e328010ac5b","article-title":"Genomic imbalances in AIDS-related lymphomas: relation with tumoral Epstein-Barr virus status","volume":"20","author":"Vaghefi","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.clml.2014.06.020_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.cco.0000432525.70099.a4","article-title":"Pathology of lymphoma in HIV","volume":"25","author":"Cesarman","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clml.2014.06.020_bib42","first-page":"67","article-title":"Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma","volume":"1","author":"Knowles","year":"1997","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.clml.2014.06.020_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/ajcp\/92.2.222","article-title":"Plasma cell malignancy in the acquired immune deficiency syndrome","volume":"92","author":"Voelkerding","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2014.06.020_bib44","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/cncr.10368","article-title":"Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection","volume":"94","author":"Levine","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.06.020_bib45","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/1097-0142(19900915)66:6<1130::AID-CNCR2820660609>3.0.CO;2-0","article-title":"Cutaneous T-cell lymphoma in a patient infected with human immunodeficiency virus type 1. Use of radiation therapy","volume":"66","author":"Goldstein","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.06.020_bib46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.leukres.2003.10.020","article-title":"Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literature","volume":"6","author":"Tsimberidou","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2014.06.020_bib47","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood-2009-11-253039","article-title":"The role of tumor histogenesis, FDG-PET and short course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV associated diffuse large B cell lymphoma","volume":"115","author":"Dunleavy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.06.020_bib48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJM198408303110904","article-title":"Non-Hodgkin lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome","volume":"311","author":"Ziegler","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.06.020_bib49","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2391::AID-CNCR29>3.0.CO;2-0","article-title":"The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma","volume":"86","author":"Rossi","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.06.020_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s15010-009-9019-1","article-title":"Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy","volume":"38","author":"Francisci","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.clml.2014.06.020_bib51","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group","volume":"336","author":"Kaplan","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.06.020_bib52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/CCO.0b013e3283094ec7","article-title":"Management of AIDS-related lymphoma","volume":"20","author":"Levine","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clml.2014.06.020_bib53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/QAD.0b013e32834f30fa","article-title":"Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients","volume":"26","author":"Wyen","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.clml.2014.06.020_bib54","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.V100.5.1634.h81702001634_1634_1640","article-title":"Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)","volume":"100","author":"Sparano","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.06.020_bib55","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.06.020_bib56","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.06.020_bib57","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus associated Burkitt lymphoma","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.06.020_bib58","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt lymphoma","volume":"369","author":"Dunleavy","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.06.020_bib59","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","article-title":"Durable remissions with autologous stem cell\u00a0transplantation for high risk HIV associated lymphomas","volume":"105","author":"Krishnan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.06.020_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbmt.2007.03.014","article-title":"Dose reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus associated lymphomas: AIDS Malignancy Consortium Study 020","volume":"14","author":"Spitzer","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2014.06.020_bib61","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","article-title":"Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients","volume":"122","author":"Barta","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.06.020_bib62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.hoc.2005.05.004","article-title":"AIDS-related primary central nervous system lymphoma","volume":"19","author":"Kasamon","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"suppl 3","key":"10.1016\/j.clml.2014.06.020_bib63","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13550280500511808","article-title":"Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era","volume":"11","author":"Cingolani","year":"2005","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.clml.2014.06.020_bib64","series-title":"Virology","first-page":"2397","article-title":"Epstein-Barr virus","author":"Rickinson","year":"1996"},{"key":"10.1016\/j.clml.2014.06.020_bib65","series-title":"The Medical Management of AIDS","first-page":"460","article-title":"AIDS-associated toxoplasmosis","author":"Wong","year":"1995"},{"key":"10.1016\/j.clml.2014.06.020_bib66","first-page":"1366","article-title":"Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients","volume":"39","author":"Lorberboym","year":"1998","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.clml.2014.06.020_bib67","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/01.wnl.0000261909.28915.83","article-title":"CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies","volume":"68","author":"Broomberg","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.clml.2014.06.020_bib68","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2007.12.5062","article-title":"Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma","volume":"25","author":"Shah","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2014.06.020_bib69","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/neuonc\/noq011","article-title":"High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma","volume":"12","author":"Chamberlain","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clml.2014.06.020_bib70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/COH.0b013e32831a722b","article-title":"HIV-associated Hodgkin lymphoma","volume":"4","author":"Carbone","year":"2009","journal-title":"Curr Opin HIV\/AIDS"},{"key":"10.1016\/j.clml.2014.06.020_bib71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2014.06.020_bib72","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1182\/blood-2006-09-047498","article-title":"Commentary: Hodgkin lymphoma: to the HAART of the matter","volume":"108","author":"Levine","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.06.020_bib73","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2014.06.020_bib74","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0959-8049(01)00122-8","article-title":"Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals","volume":"37","author":"Vaccher","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clml.2014.06.020_bib75","first-page":"444","volume":"15","author":"Levine","year":"2000","journal-title":"J\u00a0AIDS"},{"key":"10.1016\/j.clml.2014.06.020_bib76","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdg408","article-title":"BEACOPP therapeutic regimen for patients with Hodgkin disease and HIV infection","volume":"14","author":"Hartmann","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2014.06.020_bib77","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","article-title":"Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection","volume":"100","author":"Spina","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.06.020_bib78","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1200\/JCO.2012.44.8373","article-title":"Management of HIV-associated Hodgkin lymphoma: how far we have come","volume":"30","author":"Kaplan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2014.06.020_bib79","first-page":"125","article-title":"AIDS-related malignancies\u2013a new approach","volume":"10","author":"Valencia Ortega","year":"2008","journal-title":"AIDS Rev"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501400175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501400175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:26:05Z","timestamp":1761870365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226501400175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":79,"alternative-id":["S215226501400175X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2014.06.020","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-Related Hematological Malignancies: A\u00a0Concise Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2014.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}